Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
- Written by PR Newswire Asia - Daily Bulletin Au RSS
Authors: PR Newswire Asia - Daily Bulletin Au RSS
Read more http://www.prnasia.com/story/archive/4871636_CN71636_0





